Abstract P1-10-14: Abemaciclib tablet formulation is bioequivalent to capsules
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs17-p1-10-14
Abstract: Introduction: Abemaciclib is being developed for the treatment of cancer, including advanced and metastatic breast cancer. Tablet formulations, which are smaller than the capsules used in the pivotal MONARCH 1, 2 and 3 breast cancer… read more here.
Keywords: part; fasted state; cancer; bioequivalent capsules ... See more keywords